Rovi
| Laboratorios Farmacéuticos Rovi, SA | |
|---|---|
| legal form | Sociedad Anónima |
| ISIN | ES0157261019 |
| founding | 1946 |
| Seat |
Pozuelo de Alarcón , Spain
|
| management | Juan López-Belmonte Encina ( CEO ) |
| Number of employees | 1209 |
| sales | 303.2 million euros |
| Branch | Pharma |
| Website | www.rovi.es/en |
| As of December 31, 2018 | |
Laboratorios Farmacéuticos Rovi (Rovi) is a Spanish pharmaceutical company. The company was founded in 1946 and began developing anti-coagulant heparins with low molecular weight in 1981 , which are among the most important products today. A number of prescription drugs are also manufactured and sold under license from Merck & Co. and Novartis , among others . The contract manufacturing on behalf of other manufacturers is another mainstay Rovis.
Since 2019 Rovi is part of the Spanish small cap stocks index IBEX Small Cap .
Individual evidence
- ↑ Rovi: Board of Directors accessed April 19, 2019
- ↑ Rovi: Consolidated Annual Accounts and Consolidated Management Report at December 31, 2018, accessed April 19, 2019
- ↑ Rovi: History accessed April 19, 2019
- ^ Rovi: Prescription Pharmaceuticals accessed April 19, 2019
- ↑ Expansión: Prosegur Cash sustituirá a Europac en el Ibex Medium Cap accessed on April 19, 2019